glp-1 discovery GLP-1-based therapies for diabetes, obesity and beyond Discovery of novel glucagon-like peptide

Research Note: Ipamorelin's selective GH release without significant cortisol/prolactin elevation is documented in Raun and Ankersen's pharmacology papers (PMID 9849822, PMID 9733495), and CJC-1295's tolerability was assessed in Teichman et al.'s Phase 1/2 trial (PMID 16352683)

James Stirrett, ND GLP-1 Microdosing vs

Berberine is not unstudied

Medical professionals recommend consulting with a healthcare professional before undergoing any fat reduction treatment

I dont know what to do- stop antibiotics

From subtle Botox and natural-looking lip filler to NAD+ infusions, GLP-1 weight loss and concierge primary care we deliver evidence-based treatments in a warm, unhurried setting